case-study

Transforming Global Pharma: The Road to Digital Success

digital transformation in pharma case study

Goal

The main goal is to create a successful example of a global pharmaceutical company’s digital transformation. To match our customer’s ambitions (reduce production budget and terms in a first place), we analyzed the full potential of the company’s business models and created a plan.

So, the purpose of our digital transformation efforts was to create a flexible ecosystem for standardized content management based on the modular approach and master templates that can be localized globally, starting with the smart content management framework for 1 brand.

Challenges

  • The pharma company experienced a lack of standardized content production and re-use system.
  • A habitual way of content creation resulted in a long time-to-market and high development costs.  
  • A lot of manual effort resulted in low effectiveness of content creation and no content was reused across different distribution channels.

Solution

The key solution for this project is to build a flexible digital ecosystem for content creation team. This ecosystem supposed to cover the most frequent issues related to the content development:

  • the long-term issues and hurdles of MLR optimization,
  • taxonomy management,
  • content reuse and repurpose.

Once the content development system is established, we provide onboarding for marketing teams and managers. This is a highly effective measure of immersing the team in the updated context of the digital content development. Effective change management should help individuals affected by business and technical changes to quickly adapt to the new marketing approaches and methods.

Impact

This pharma transformation case-study presents the introduction of an integrated end-to-end content production model implying faster MLR approval and higher cost efficiency with a carefully planned change management example.

The case considers a global pharmaceutical company specializing in innovative medicines for people with rare diseases addressed Viseven to build an integrated end-to-end content production model. This model allows to centralize the process and enable content creation at scale, faster MLR approval, and higher cost- efficiency.

Latest News

May 16, 2022

Viseven and Next Pharma Partnership Announcement

Viseven is happy to share its latest business venture – a partnership with NEXT. The two companies join forces to positively impact the future of the
May 11, 2022

24/7 Content Factory: Center of Excellence in India  

We are proud to announce the development of our latest business venture – a brand new Center of Excellence which is much more than just a
May 4, 2022

How to Solve MLR Hurdles with a Modular Approach

Find out about the main pain points of MLR approval process and how you can fix and make these actions predictable and faster